ABCB1 and squamous cell carcinoma: They demonstrated that migrastatin increases the intracellular concentration of anticancer drugs vinblastine, vincristine and taxol in P-glycoprotein-overexpressing VJ-300 (vincristine-resistant human epidermoid carcinoma) [84] and P388/VCR (vincristine-resistant mouse leukemia) cells [85].